About Raygenome Labs Private Limited
Data last updated:
Raygenome Labs Private Limited is a private limited company based in Pune, Maharashtra, India, a subsidiary of Personome Medicine Private Limited. It operates in the diagnostic centers and pathology labs segment of the healthcare sector. It was incorporated on 03 August 2016 and has been in existence for over 10 years.
The company is registered with the Registrar of Companies (ROC), Pune, under CIN U74999PN2016PTC165849. Its GSTIN is 27AAKCM4846M1ZT (Maharashtra).
The company has an authorised share capital of ₹2 Cr and a paid-up capital of ₹87.5 Lakh. It was formerly known as Megavision Life Sciences Private Limited. It is led by directors Sharvari Aniket Ausekar and Poonam Adarsh Nigam.
Its last annual general meeting (AGM) was held on 20 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Pune, Maharashtra.
As per the financials filed for FY 2025, the company reported a revenue of ₹2.06 Cr, reflecting significant growth compared to the previous year. For the same year it recorded a net profit of ₹11.21 Lakh (net margin 5.5%) and EBITDA of ₹15.8 Lakh (EBITDA margin 7.7%). Revenue has grown at a compounded annual rate (CAGR) of 88% over three years and 14% over five years.
The company has 2 deals on record (1 acquisition, 1 funding round), with disclosed funding of ₹55 Lakh; the latest was in November 2017.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website megavisionlifesciences.com.
Company details
Contact details
Raygenome Labs Private Limited's registered office is in Pune, Maharashtra. Its website is megavisionlifesciences.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressFlat No2 Apoorva Apartment, S.No.82/B Plot No.16 Sahakar Ngr Behind Walimbe Eye Clinic, Pune, Maharashtra, India – 411009
- IndustryHealthcare, Diagnostic Centers & Pathology Labs
To see the full contact details of Raygenome Labs Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Raygenome Labs is hospital and medical care. In detail, this covers medical and dental practice, nursing, pathology, blood bank services, etc..
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| Q | Hospital and Medical Care | Q2 | Medical and dental practice, Nursing, pathology, blood bank services, etc. |
To see the full business activity and turnover split of Raygenome Labs Private Limited, buy the company report.
Financials of Raygenome Labs Private Limited
FY 2025 filings availableRaygenome Labs Private Limited reported revenue of ₹2.06 Cr (up 1130% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 14% over five years. EBITDA rose 19% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹15.8 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹11.21 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 7.7% | ||||
| Net Profit Margin | 5.5% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Raygenome Labs Private Limited, buy the company report.
Board of directors of Raygenome Labs Private Limited
Raygenome Labs has 2 current directors and 8 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sharvari Aniket Ausekar | Director | 25 Jul 2025 | 1 Years 3 Months | Current |
| Poonam Adarsh Nigam | Director | 14 Jun 2024 | 2 Years 4 Months | Current |
Auditor
Raygenome Labs Private Limited is audited by TEJAS A. JOSHI & CO. for the financial year 2022.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| TEJAS A. JOSHI & CO. | FY 2022 | 130077W |
Shareholding
The shareholding of Raygenome Labs Private Limited is on record for 5 financial years, the latest being FY 2022, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Raygenome Labs Private Limited, buy the company report.
Deals & funding
Raygenome Labs Private Limited has 2 deals on record (1 acquisition, 1 funding round), with disclosed funding of ₹55 Lakh; the latest was in November 2017.
Deals on record (2 of 2)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Nov 2017 | Acquisition | ₹7.37 Cr | Buyer: Personome Medicine Private Limited Seller: 2 individuals |
| Nov 2016 | Funding round | ₹55 Lakh | Investors: 3 individuals |
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
No court or tribunal cases involving Raygenome Labs Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Raygenome Labs Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Raygenome Labs has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAKCM4846M1ZT | Maharashtra | Active | 20 Aug 2018 |
To see the full GST registrations and return filing status of Raygenome Labs Private Limited, buy the company report.
Recent activity
Raygenome Labs Private Limited has 11 board changes on record since 2020: 3 appointments and 8 cessations. The latest: Sharvari Aniket Ausekar ceased to be Additional Director on 19 Sep 2025.
2 earlier events are in the company report.
Frequently asked questions
Raygenome Labs is an active private limited company based in Pune, Maharashtra, India. The company works in diagnostic centers and pathology labs, within the healthcare industry. It was incorporated on 03 August 2016 (10+ years old) and is registered under CIN U74999PN2016PTC165849.
Raygenome Labs has 2 current directors:
- Sharvari Aniket Ausekar - Director
- Poonam Adarsh Nigam - Director
The latest financial statements of Raygenome Labs on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 20 September 2025. Year-wise statements from FY 2017 are in the company report.
The GSTIN of Raygenome Labs is 27AAKCM4846M1ZT, registered in Maharashtra.
The CIN (Corporate Identification Number) of Raygenome Labs is U74999PN2016PTC165849. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Raygenome Labs was incorporated on 03 August 2016, making it 10+ years old. It is registered with the Registrar of Companies, Pune.
Raygenome Labs has 2 deals on record (1 acquisition, 1 funding round), with disclosed funding of ₹55 Lakh; the latest was in November 2017.
Sharvari Aniket Ausekar ceased to be Additional Director on 19 Sep 2025. Sharvari Aniket Ausekar was appointed as Director on 25 Jul 2025. Poonam Adarsh Nigam ceased to be Additional Director on 21 Aug 2024. Raygenome Labs has 11 board changes on record in total.
Raygenome Labs can be reached through the website megavisionlifesciences.com. Its registered office is in Pune, Maharashtra, India.
The registered office of Raygenome Labs is at Flat No2 Apoorva Apartment, S.No.82B Plot No.16 Sahakar Ngr Behind Walimbe Eye Clinic, Pune, Maharashtra, India – 411009.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
